Human myeloperoxidase in innate and acquired immunity

被引:214
作者
Arnhold, Juergen [1 ]
Flemmig, Joerg [1 ]
机构
[1] Univ Leipzig, Fac Med, Inst Med Phys & Biophys, D-04107 Leipzig, Germany
关键词
Myeloperoxidase; Polymorphonuclear leukocytes; Inflammation; Innate immunity; Acquired immunity; Disease progression; LOW-DENSITY-LIPOPROTEIN; COLONY-STIMULATING FACTOR; HUMAN EOSINOPHIL PEROXIDASE; HUMAN ALPHA-1-PROTEINASE INHIBITOR; DELAYS NEUTROPHIL APOPTOSIS; OXIDE SYNTHASE EXPRESSION; NECROSIS-FACTOR-ALPHA; FLAVANOL-RICH COCOA; ACTIVATION IN-VITRO; APOLIPOPROTEIN-A-I;
D O I
10.1016/j.abb.2010.04.008
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Polymorphonuclear leukocytes (PMNs) are important players in innate and acquired immunity. These cells accumulate at inflammatory sites and contribute to host defence, regulation of the inflammatory process, and also to tissue injury. One of the key components of PMNs is the heme-containing enzyme myeloperoxidase (MPO) that is stored in large amount in azurophilic granules of resting cells. Here we review the (patho)physiological role of MPO from the viewpoint of participation of PMNs in immune reactions. Myeloperoxidase is able to catalyse a wide range of one- and two-electron substrate oxidations. With special products, MPO contributes to apoptosis induction in PMNs and other cells, and, thus, to termination of inflammatory response. On the other hand. MPO released from necrotic cells promotes an inflammation by further recruitment of PMNs, and chemical modification of proteins and other tissue constituents. Myeloperoxidase is a fascinating, multifunctional, and challenging enzyme that hasn't yet revealed all its secrets. (C) 2010 Elsevier Inc. All rights reserved.
引用
收藏
页码:92 / 106
页数:15
相关论文
共 318 条
[41]   Kinetics of oxidation of aliphatic and aromatic thiols by myeloperoxidase compounds I and II [J].
Burner, U ;
Jantschko, W ;
Obinger, C .
FEBS LETTERS, 1999, 443 (03) :290-296
[42]  
BUYN J, 1999, FEBS LETT, V455, P243
[43]   Myeloperoxidase binds to low-density lipoprotein: potential implications for atherosclerosis [J].
Carr, AC ;
Myzak, MC ;
Stocker, R ;
McCall, MR ;
Frei, B .
FEBS LETTERS, 2000, 487 (02) :176-180
[44]   INTERLEUKIN-12 PRODUCTION BY HUMAN POLYMORPHONUCLEAR LEUKOCYTES [J].
CASSATELLA, MA ;
MEDA, L ;
GASPERINI, S ;
DANDREA, A ;
MA, XJ ;
TRINCHIERI, G .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1995, 25 (01) :1-5
[45]   LEUKOCYTE MYELOPEROXIDASE DEFICIENCY AND DIABETES-MELLITUS ASSOCIATED WITH CANDIDA-ALBICANS LIVER-ABSCESS [J].
CECH, P ;
STALDER, H ;
WIDMANN, JJ ;
ROHNER, A ;
MIESCHER, PA .
AMERICAN JOURNAL OF MEDICINE, 1979, 66 (01) :149-153
[46]  
CECH P, 1984, BLOOD, V63, P88
[47]   Chlorination of bacterial and neutrophil proteins during phagocytosis and killing of Staphylococcus aureus [J].
Chapman, ALP ;
Hampton, MB ;
Senthilmohan, R ;
Winterbourn, CC ;
Kettle, AJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (12) :9757-9762
[48]   Inhibition of apoptosis in polymorphonuclear neutrophils from burn patients [J].
Chitnis, D ;
Dickerson, C ;
Munster, AM ;
Winchurch, RA .
JOURNAL OF LEUKOCYTE BIOLOGY, 1996, 59 (06) :835-839
[49]   Ablation of the inflammatory enzyme myeloperoxidase mitigates features of Parkinson's disease in mice [J].
Choi, DK ;
Pennathur, S ;
Perier, C ;
Tieu, K ;
Teismann, P ;
Wu, DC ;
Jackson-Lewis, V ;
Vila, M ;
Vonsattel, JP ;
Heinecke, JW ;
Przedborski, S .
JOURNAL OF NEUROSCIENCE, 2005, 25 (28) :6594-6600
[50]   ACTIVITY OF POLYMORPHONUCLEAR LEUKOCYTES IN THE PRESENCE OF SULFIDE [J].
CLAESSON, R ;
GRANLUNDEDSTEDT, M ;
PERSSON, S ;
CARLSSON, J .
INFECTION AND IMMUNITY, 1989, 57 (09) :2776-2781